Copper(II) dithiosemicarbazone

DB16963InvestigationalSmall molecule

Copper(II) dithiosemicarbazone: Overview.

Mechanism: Pharmacologically active on Nuclear receptor coactivator 4
Curator reviewed
Formula / weight: C₈H₁₄CuN₆S₂ · 321.91 g/mol (avg)
Also known as: Atsm copper (ii) · Copper, ((2,2'-(1,2-dimethyl-1,2-ethanediylidene)bis(n-methylhydrazinecarbothioamidato-.kappa.n2,.kappa.s))(2-))-, (sp-4-2)- · Copper(ii) diacetyl-di(n4-methyl)thiosemicarbazone · Cu-atsm · Cu(ii)atsm

Resolves to

Compound

Structure

InChIKeySBHDKYTVDCRMOE-JPAPVDFESA-LSMILES[Cu++].CN\C([S-])=N\N=C(/C)\C(\C)=N\N=C(/[S-])NC

Targets

What you can answer from here — as of October 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Copper(II) dithiosemicarbazone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.